Recent Updates
Recently added Catalysts

dual-chamber syringe

Phase 1

Healthy | Unknown | Other |Pfizer, Inc.|Last Updated: May 2, 2014

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLED
Total Trials1
Total Enrollment48
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01747928Users Study Of The Caverject Delivery SystemEARLY_PHASE1 COMPLETED 48Mar 1, 2013Mar 1, 2013May 2, 20141 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Delivery System Success Rate (DSSR)
Day 1

DSSR was defined as percentage of participants who were able to successfully expel the selected dose from the Caverject Impulse Dual Chamber Delivery System when relying on the modified Instructions for Use (IFU). The process was considered successful if the attempt was observed and documented by study personnel AND the participant didn't receive any operational/"hands on" demonstration on how to operate the plunger from study personnel AND after performing all preparatory steps, the participant was able to expel the dose to the selected plunger stop-point without any unexpected interruption.

Secondary Endpoints
Number of Participants With Categorical Responses to the Participant Assessment Tool (PAT): Instructions Provided Were Useful?
Day 1
Number of Participants With Categorical Responses to the PAT: Instructions Provided Were Clear?
Day 1
Number of Participants With Categorical Responses to the PAT: Most Difficult Step?
Day 1
Unlock Study Endpoints
Study Design & Arms
MaskingNONE
ModelPARALLEL
Treatment Arms
ArmTypeDescription
Group 1EXPERIMENTAL -
Interventions
NameTypeDescription
dual-chamber syringeOTHERdual-chamber syringe for mock injection
Unlock Study Design Details
Eligibility Criteria
Age Range40 Years — 70 Years
SexMALE
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Healthy males Exclusion Criteria: * Inability to read English; * physical limitations preventing participant from operating the syringe

Countries:United States
Unlock Eligibility Criteria